Substantially antiviral agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line Vero Cells Cells, Cultured HeLa Cells Cell Line, Tumor Capsid Liver CD8-Positive T-Lymphocytes L Cells (Cell Line)T-Lymphocytes, Cytotoxic HEK293 Cells CD4-Positive T-Lymphocytes Fibroblasts Virion

Organisms46

Hepacivirus HIV-1 Cercopithecus aethiops Cytomegalovirus Simplexvirus Viruses Influenza A Virus, H1N1 Subtype Influenza B virus Influenza A virus Orthomyxoviridae Hepatitis B virus HIV Herpesvirus 1, Human Herpesviridae Herpesvirus 2, Human Enterovirus A, Human Influenza A Virus, H3N2 Subtype Influenza A Virus, H5N1 Subtype Vesicular stomatitis Indiana virus Herpesvirus 3, Human Vaccinia virus Mice, Inbred BALB C Encephalomyocarditis virus SARS Virus Cricetinae Dogs Sendai virus Vesiculovirus Capsid Lymphocytic choriomeningitis virus RNA Viruses Mengovirus Rhinovirus Mice, Inbred C57BL Muromegalovirus Enterovirus B, Human Sindbis Virus Arenavirus Filoviridae Alphavirus Mice, Knockout Newcastle disease virus Ectromelia virus Dengue Virus Thogotovirus Virion

Diseases23

Influenza, Human Virus Diseases Herpes Simplex Cytomegalovirus Infections Hepatitis B, Chronic Hepatitis C, Chronic Hepatitis C Eye Infections, Viral Hepatitis B Herpes Zoster Herpesviridae Infections Orthomyxoviridae Infections HIV Infections RNA Virus Infections Disease Models, Animal Vesicular Stomatitis Recurrence Rhabdoviridae Infections Lymphocytic Choriomeningitis Arenaviridae Infections Vaccinia Viremia Alphavirus Infections

Chemicals and Drugs87

Antiviral Agents Acyclovir Organophosphonates Rimantadine Amantadine Trifluridine Oseltamivir Interferons Nucleosides Ribavirin Zanamivir Ganciclovir Cytosine Foscarnet Prodrugs Interferon-alpha Idoxuridine Zalcitabine Organophosphorus Compounds RNA, Viral Ribonucleosides Adenine 2-Aminopurine Anti-HIV Agents Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Viral Nonstructural Proteins Arabinonucleotides Vidarabine Phosphate Interferon Type I DNA, Viral Arabinofuranosyluracil Vidarabine Neuraminidase Interferon-beta Dideoxynucleosides Myxovirus Resistance Proteins Isoxazoles Influenza Vaccines Protease Inhibitors Guanine RNA Replicase Polyethylene Glycols Ribosome Inactivating Proteins, Type 1 HIV Protease Inhibitors Acetamides Guanidines Recombinant Proteins 2',5'-Oligoadenylate Synthetase HIV Protease Interferon Regulatory Factor-3 Valine Thymidine Kinase DEAD-box RNA Helicases HIV Reverse Transcriptase RNA, Double-Stranded DNA-Directed DNA Polymerase Thymidine Amides Enzyme Inhibitors Poly I-C Oligopeptides Peptides Viral Envelope Proteins Recombinant Fusion Proteins Interferon Inducers eIF-2 Kinase Receptors, Interferon Antibodies, Viral Interferon-gamma STAT2 Transcription Factor Receptor, Interferon alpha-beta Cytidine Deaminase N-Glycosyl Hydrolases Toll-Like Receptor 3 STAT1 Transcription Factor Antigens, Viral Interferon Regulatory Factor-7 Antineoplastic Agents vif Gene Products, Human Immunodeficiency Virus RNA, Small Interfering Interferon-Stimulated Gene Factor 3, gamma Subunit RNA Helicases Cytokines

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Viral Plaque Assay Inhibitory Concentration 50 Drug Therapy, Combination Drug Evaluation, Preclinical Cytopathogenic Effect, Viral Viral Load Drug Design Models, Molecular Microbial Sensitivity Tests Treatment Outcome Administration, Topical Administration, Oral Disease Models, Animal Liver Transplantation Clinical Trials as Topic Models, Biological Polymerase Chain Reaction Magnetic Resonance Spectroscopy Transfection Chromatography, High Pressure Liquid

Phenomena and Processes38

Virus Replication Drug Resistance, Viral Inhibitory Concentration 50 Virus Internalization Cytopathogenic Effect, Viral Viral Load Structure-Activity Relationship Replicon Virus Activation Amino Acid Sequence Molecular Structure Immunity, Innate Mutation Virus Assembly Dose-Response Relationship, Drug Time Factors Base Sequence Genotype Immunocompromised Host RNA, Double-Stranded Drug Resistance, Microbial Protein Binding Host-Pathogen Interactions Cell Survival Binding Sites Drug Synergism Kinetics Virus Physiological Phenomena Protein Conformation RNA Interference Transfection Substrate Specificity Signal Transduction Gene Expression Regulation, Viral Viral Interference Immune Evasion Pregnancy Gene Expression Regulation

Disciplines and Occupations1

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Health Care4

Post-Exposure Prophylaxis Disease Outbreaks Treatment Outcome Clinical Trials as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antiviral Agents Virus Replication Acyclovir Organophosphonates Rimantadine Drug Resistance, Viral Amantadine Trifluridine Oseltamivir Viral Plaque Assay Interferons Nucleosides Influenza, Human Ribavirin Zanamivir Ganciclovir Hepacivirus Cell Line Cytosine Vero Cells Virus Diseases Foscarnet Prodrugs Interferon-alpha HIV-1 Cercopithecus aethiops Idoxuridine Cytomegalovirus Zalcitabine Organophosphorus Compounds RNA, Viral Simplexvirus Ribonucleosides Viruses Adenine Influenza A Virus, H1N1 Subtype 2-Aminopurine Anti-HIV Agents Influenza B virus Influenza A virus Post-Exposure Prophylaxis Orthomyxoviridae Hepatitis B virus Herpes Simplex Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Inhibitory Concentration 50 Cytomegalovirus Infections Hepatitis B, Chronic Viral Nonstructural Proteins Hepatitis C, Chronic HIV Herpesvirus 1, Human Arabinonucleotides Vidarabine Phosphate Interferon Type I Molecular Sequence Data DNA, Viral Arabinofuranosyluracil Drug Therapy, Combination Virus Internalization Drug Evaluation, Preclinical Vidarabine Cytopathogenic Effect, Viral Herpesviridae Hepatitis C Viral Load Neuraminidase Herpesvirus 2, Human Drug Design Structure-Activity Relationship Cells, Cultured Enterovirus A, Human Eye Infections, Viral Interferon-beta Hepatitis B Dideoxynucleosides Myxovirus Resistance Proteins Isoxazoles Influenza A Virus, H3N2 Subtype Herpes Zoster Influenza A Virus, H5N1 Subtype Influenza Vaccines Replicon Protease Inhibitors Guanine Virus Activation Vesicular stomatitis Indiana virus Amino Acid Sequence Herpesvirus 3, Human Vaccinia virus Herpesviridae Infections Molecular Structure Models, Molecular Orthomyxoviridae Infections HeLa Cells RNA Replicase

No FAQ available that match "substantially antiviral agents"